[ET Net News Agency, 29 June 2026] REMEGEN (09995) rose 10.4% to HK$76.9.
It hits an intra-day high of HK$76.9, breaking above the 20-D SMA of HK$70.953, and an intra-day low of HK$69.7. The total shares traded was 2.21 million, with a value of HK$163.47m. The active buy/sell ratio is 69:31, with net buying turnover of HK$58.16m. UBS accounts for greatest net responsive buying turnover of HK$6.56m, with volume weighted average price of HK$73.939. CHINA INV INFO accounts for greatest net responsive selling turnover of HK$25.2m, with volume weighted average price of HK$74.056.
Basic Information| Nominal | 76.900 | % Chg | +10.41% |
| High | 76.900 | Low | 69.700 |
| Shares Tr | 2.21m | Turnover | 163.47m |
| 10-D SMA | 69.555 | %H.V | 50.008 |
| 20-D SMA | 70.953 | VWAP | 73.897 |
| 50-D SMA | 86.730 | RSI14 | 52.789 |
Status: Breaking above the 20-D SMA, active buy/sell ratio is 69:31, with net buying turnover of HK$58.16m
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| REMEGEN (09995) | 76.90 | +10.41 |
| INNOVENT BIO (01801) | 78.80 | +4.86 |
| KEYMED BIO-B (02162) | 71.45 | +11.55 |
| XTALPI (02228) | 7.64 | +13.19 |
| WUXI BIO (02269) | 34.74 | +5.15 |
| WUXI APPTEC (02359) | 150.50 | +3.51 |
| TRANSTHERA-B (02617) | 11.25 | +23.63 |
| BEONE MEDICINES (06160) | 171.20 | +3.19 |
| SKB BIO (06990) | 440.20 | +5.31 |
| AKESO (09926) | 89.60 | +7.56 |
(ed)
